Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

Symbicort was first FDA-approved in 2006 as a treatment for asthma, followed by an extension to its label covering COPD in 2009. A further approval in 2017 in childhood asthma has helped the drug ...

Haleon plc 5.13 -2.29% Mkt Cap 46.087B IndustryDrug Manufacturers—Specialty & Generic AJANTPHARM.NS Ajanta Pharma Limited 2,520.70 -1.86% Mkt CapINR 315.398B IndustryDrug Manufacturers ...

Maritime drug smuggling remains a significant challenge for global law enforcement agencies. The use of commercial vessels, fishing boats, private yachts, and increasingly sophisticated submarines ...